Melaibari, M.; Alkreathy, H.M.; Esmat, A.; Rajeh, N.A.; Shaik, R.A.; Alghamdi, A.A.; Ahmad, A.
Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study. Biomedicines 2023, 11, 1342.
https://doi.org/10.3390/biomedicines11051342
AMA Style
Melaibari M, Alkreathy HM, Esmat A, Rajeh NA, Shaik RA, Alghamdi AA, Ahmad A.
Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study. Biomedicines. 2023; 11(5):1342.
https://doi.org/10.3390/biomedicines11051342
Chicago/Turabian Style
Melaibari, Maryam, Huda M. Alkreathy, Ahmed Esmat, Nisreen A. Rajeh, Rasheed A. Shaik, Anwar A. Alghamdi, and Aftab Ahmad.
2023. "Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study" Biomedicines 11, no. 5: 1342.
https://doi.org/10.3390/biomedicines11051342
APA Style
Melaibari, M., Alkreathy, H. M., Esmat, A., Rajeh, N. A., Shaik, R. A., Alghamdi, A. A., & Ahmad, A.
(2023). Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study. Biomedicines, 11(5), 1342.
https://doi.org/10.3390/biomedicines11051342